Serina Therapeutics annual return on equity
2018
2019
2025
Serina Therapeutics Return on Equity (ROE) Growth & History (SER)
Serina Therapeutics's return on equity was −6,351.66% for fiscal 2025.
View full Serina Therapeutics company overviewSerina Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −6,351.66% | — |
| 2019 | 2019-12-31 | −251.51% | −149.62 pp |
| 2018 | 2018-12-31 | −101.88% | — |
Serina Therapeutics quarterly return on equity
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −34.96% | +333.18 pp |
| Q1 2026 | 2026-03-31 | −78.43% | +332.59 pp |
| Q4 2025 | 2025-12-31 | −387.23% | — |
| Q3 2025 | 2025-09-30 | −257.44% | — |
| Q2 2025 | 2025-06-30 | −368.14% | — |
| Q1 2025 | 2025-03-31 | −411.02% | — |
| Q1 2020 | 2020-03-31 | −430.97% | −393.60 pp |
| Q4 2019 | 2019-12-31 | −82.69% | −39.42 pp |
| Q3 2019 | 2019-09-30 | −58.11% | — |
| Q2 2019 | 2019-06-30 | −38.45% | — |
| Q1 2019 | 2019-03-31 | −37.37% | — |
| Q4 2018 | 2018-12-31 | −43.27% | — |
Serina Therapeutics return on equity trends
Between the periods ended 2018-12-31 and 2025-12-31, Serina Therapeutics's return on equity decreased from −101.88% to −6,351.66%, a change of −6249.77 percentage points. The latest reported quarter, Q2 2026, shows −34.96%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Serina Therapeutics source filings ↗